Egypt's Abdalla highlights domestic production, inflation control at Arab banks meeting    Egypt's PM says Gaza war dominating political scene, vows to continue economic reform    Cairo governor briefs PM on Khan el-Khalili, Rameses Square development    El Gouna Film Festival's 8th edition to coincide with UN's 80th anniversary    Cairo University, Roche Diagnostics inaugurate automated lab at Qasr El-Ainy    Egypt expands medical, humanitarian support for Gaza patients    Finance Ministry presents three new investor facilitation packages to PM to boost investment climate    Egypt condemns Israeli offensive in Gaza City, warns of grave regional consequences    Egypt investigates disappearance of ancient bracelet from Egyptian Museum in Tahrir    Egypt launches international architecture academy with UNESCO, European partners    African trade ministers meet in Cairo to push forward with AfCFTA    Egypt's President, Pakistan's PM condemn Israeli attack on Qatar    Egypt signs MoUs with 3 European universities to advance architecture, urban studies    Madrid trade talks focus on TikTok as US and China seek agreement    Egypt's Sisi, Qatar's Emir condemn Israeli strikes, call for Gaza ceasefire    Egypt condemns terrorist attack in northwest Pakistan    Egyptian pound ends week lower against US dollar – CBE    Egypt hosts G20 meeting for 1st time outside member states    Egypt to tighten waste rules, cut rice straw fees to curb pollution    Egypt seeks Indian expertise to boost pharmaceutical industry    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egyptian, Ugandan Presidents open business forum to boost trade    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



FDA authorises marketing of IQOS as modified risk tobacco product
Published in Daily News Egypt on 13 - 07 - 2020

Philip Morris International (PMI) announced that the US Food and Drug Administration (FDA) has authorised the marketing of the IQOS, PMI`s electrically heated tobacco device, as a modified risk tobacco product (MRTP).
During a virtual conference on Monday, PMI noted that the device is the first and only electronic nicotine product to be granted marketing orders through the FDA's MRTP process
As a result of the FDA decision, the company presented its next steps as part of its bold ambition to encourage those smokers who would otherwise continue smoking cigarettes to switch to alternatives deemed better, based on scientific research, like the IQOS,.
"In my view, we are witnessing a historic moment, not only for PMI but for public health, because to understand the context today, for many years, tobacco control policies have focused on restrictive marketing and fiscal measures, to convince people to quit or prevent them from starting cigarette smoking," said André Calantzopoulos, CEO of PMI, "And to a very large degree, these are appropriate measures but they have, in many countries worldwide, reached a limitation, and unfortunately we still have 1 billion people who smoke."
Calantzopoulos added, "Restricted measures on cigarettes must continue, but it's pretty clear that as technology has advanced and there are products that has no tobacco combustion, so these products are better alternatives to cigarettes and produce less harmful substances."
He also said that governments around the world should adopt a two-pronged policy of creating different regulations for smart smoking alternatives that are scientifically reviewed, and the continuation of restrictive measures on cigarette smoking.
"I do hope we'll put at least an end to the debate on whether all tobacco products are the same, as the answer is no," Calantzopoulos said, "It's not nicotine or tobacco that are the issue, but we all now know that it is the type of combustion that is the issue."
He noted that the FDA decision makes it possible to inform adults that switching completely to IQOS is a better choice than continuing to smoke. In addition, scientific studies have shown that switching completely from conventional cigarettes to the IQOS system reduces the body's exposure to harmful or potentially harmful chemicals.
"Through the MRTP, the FDA aims to ensure that information directed at consumers about reduced risk or reduced exposure from using a tobacco product is supported by scientific evidence and understandable," he concluded.
He said that to date, IQOS has been launched in 53 market, and had almost 15 million users in Q1 of 2019. At the same time, estimated IQOS users who have stopped smoking cigarettes and switched to the device reached 73% in Q1 of 2019.
Moira Gilchrist, Vice President of Strategic and Scientific communication at PMI, said that the FDA policy considers that nicotine and tobacco products exist on a risk continuum and should be regulated according to two relevant pathways.
The first of this would mean that new tobacco products are authorised for commercialisation, determined by whether the product is appropriate for the protection of public health.
"The second pathway is the MRTP in which the tobacco product is authorised as a modified risk tobacco product with reduced risk or reduced exposure information," Gilchrist said, "PMI went through the two processes, so that customers know it is appropriate for health of the public."
Gilchrist noted that PMI had submitted multidisciplinary scientific research to the FDA, alongside consumer perception and behaviour assessments, to present a full package of information for the agency to scrutinise.
The FDA reviewed all available science and confirmed that the IQOS device is distinctly different from cigarettes. This is due to their heating tobacco rather than burning it, significantly reducing the production of harmful and potentially harmful chemicals. PMI noted that now is the time to rapidly encourage adult smokers away from cigarettes, as scientifically substantiated alternatives that are better, such as the IQOS, represent a public health opportunity.


Clic here to read the story from its source.